Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer
Portrait of the PI3K/AKT pathway in colorectal cancer - ScienceDirect
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis - The Lancet Oncology
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations | Journal of Clinical Pathology
PIK3CA point mutation rates in TCGA cohorts. Analysis of TCGA cohorts... | Download Scientific Diagram
Aspirin Use Not Associated With Survival in PIK3CA-Mutant Colorectal Cancer - The ASCO Post
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
PIK3CA (3q26.3) Orange + Copy Control 3 FISH Probe - Biocare Medical
Cancer-Associated PIK3CA Mutations in Overgrowth Disorders: Trends in Molecular Medicine
PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer | Cell Death & Disease
PIK3CA Mutations in Colorectal Cancer. | Download Table
The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal -
PIK3CA Biomarker | Colorectal Cancer Alliance
Summary for our hypothesis in MEK inhibitor-resistant PIK3CA mt colon... | Download Scientific Diagram
Clinical Characteristics and Prognostic Values of PIK3CA Mutation in Colorectal Cancer Patients
Mutation of the PIK3CA oncogene in human cancers | British Journal of Cancer
Colorectal Cancer and the Targets involved in Mechanism of It- CUSABIO
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited | Cellular and Molecular Life Sciences
Frontiers | PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients - Mirzapoor Abbasabadi - 2023 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway | Molecular Medicine | Full Text
Targeting PI3K Signaling as a Therapeutic Approach for Colorectal Cancer - ScienceDirect
